Tag Archives: Eli Lilly
Washington: The US Food and Drug Administration has granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues.
Washington: The US Food and Drug Administration on Wednesday approved Basaglar (insulin glargine injection), a long-acting human insulin analogue to improve glycaemic control in adult and paediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
Washington: The US Food and Drug Administration has approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the oesophagus joins the stomach.
Washington: The US Food and Drug Administration (FDA) has expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, albumin-bound) to treat patients with late-stage (metastatic) pancreatic cancer.
New Delhi: Terming non-communicable diseases (NCDs) as “silent killers” which are rising gradually and affecting the country’s productivity, experts from the field on Friday said that an effective public-private partnership (PPP) could tackle the problem.
New Delhi: A five-year programme to fight the rising burden of non-communicable diseases (NCDs) in India with an initial focus on improving outcomes for people with diabetes and high blood pressure was launched here on Thursday.
New Delhi: Pharmaceutical companies and research institutions in association with the Bill and Melinda Gates Foundation have stepped up efforts to aid research on a new drug for tuberculosis (TB), a disease that annually kills about three lakh people in India.
New Delhi: A report by the parliamentary standing committee for health and family welfare, which looked at the functioning of the Central Drugs Standard Control Organization (CDSCO), reveals that 33 new medicines were approved by the country’s highest office on drugs between January 2008 and October 2010, without the medicines undergoing human trials.
Washington: Siemens Healthcare has introduced an integrated diagnostic imaging solution for the detection of amyloid plaques — one of the necessary pathological features of Alzheimer’s disease — in the living brain.
Washington: Mylan Pharmaceuticals has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olanzapine Tablets USP, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg.